[摘要] 目的 探讨舒洛地特对糖尿病患者24h尿蛋白定量的影响。方法 選取2015年1月～2016年6月在我院进行糖尿病肾病治疗的94例患者作为研究对象，将其随机分成观察组47例(舒洛地特治疗)和对照组47例(常规治疗)，对比两组治疗对患者的影响。结果 两组患者经过不同的治疗后，观察组不良症状发生率为2.13%，对照组不良症发生率为10.64%，且观察组患者在24h尿蛋白定量以及尿白蛋白排泄率方面均优于对照组，差异有统计学意义(P<0.05)。结论 应用舒洛地特对糖尿病肾病患者而言，可明显减少尿蛋白量，显著降低糖尿病肾病患者的蛋白尿，这也说明舒洛地特可抑制糖尿病肾病向终末期肾病的恶化速度。

    [关键词] 舒洛地特；糖尿病肾病；24h尿蛋白定量

    [中图分类号] R587.2 [文献标识码] A [文章编号] 2095-0616(2017)06-34-03

    [Abstract] Objective To explore the impact of Shuluo ground to 24-hour urine protein quantitation in patients with diabetes. Methods 94 cases of diabetic nephropathy patients cured in our hospital from January 2015 and June 2015 were selected as the research object. They were randomly divided into observation group(treated with ShuLuo) and control group(treated with routine method) with 47 cases in each. The influence of treatment for the patient in the two groups were compared. Results After different treatment ......